Health Care & Life Sciences » Biotechnology | Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 18.13 M
Public Float
 17.03 M
Applied Genetic Technologies Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $0.1
Market Cap
 $68.66 M
Shares Outstanding
 18.17 M
Public Float
 12.38 M

Profile

Address
14193 NW
Alachua Florida 32615
United States
Employees -
Website http://www.agtc.com
Updated 07/08/2019
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W.

Financials

View All
Created with Highcharts 5.0.14Applied Genetic Technologies Corp.Net Income. Fiscal year is July-June. All values USD Thousands.4 9904 99015 90815 90824 31824 3181 3811 38140740721 30021 30020132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Applied Genetic Technologies Corp.Sales/Revenue. Fiscal year is July-June. All values USD Thousands.00002 3542 35447 36147 36139 47339 47324 18624 186201320142015201620172018010k20k30k40k50k

Susan B. Washer
President, Chief Executive Officer & Director
David R. Knop
Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.